Cancer Treatment: Waiting Times

12. What steps he is taking to reduce the waiting time from receiving a cancer diagnosis to first treatment.

In February, the faster diagnosis standard was met for the first time. In addition, we are investing in additional screening, testing and tech in order to detect cancer much earlier.

Recent data for the Buckinghamshire, Oxfordshire and Berkshire West ICB shows that 42.6% of cancer patients are waiting more than 62 days for treatment. That will only get worse without a significant programme of upgrading radiotherapy equipment and ensuring that there is a skilled workforce of radiographers. So what steps is my right hon. Friend taking to ensure that new, cutting-edge radiotherapy equipment is making it to the frontline, coupled with a fully staffed workforce to operate it and save those lives?

My hon. Friend is right to highlight the interaction of workforce and capacity in equipment. That is why we have 810 more consultant training places over three years, and we have grants to enable more than 1,000 nurses to train, for example, in chemotherapy and 1,400 new recruits to the cancer diagnostic workforce. Obviously, that sits alongside the expansion in capacity, including both in our surgical hubs and our expanded diagnostic centres.

My constituent had emergency surgery for a brain tumour, but this was after six months of going to the doctor repeatedly with problem headaches. Brain cancer causes 9% of cancer deaths but accounts for only 1% of cases. Sadly, my constituent is terminally ill, but he is in a position to explain his experiences. He has asked me to raise with the Secretary of State the issue of what work is being undertaken on genome sequencing, which could have a major impact on better treatment for brain cancers. It would be helpful if the Secretary of State not only answered this today but wrote to me in more detail on it.

The whole House will send their best wishes to the hon. Lady’s constituent. She raises an important point about genomics, which is why we have invested in Genomics England and 100,000 babies are being screened—that is a key programme of work. The Minister for Health and Secondary Care, my hon. Friend the Member for Colchester (Will Quince) recently hosted a roundtable with key stakeholders on that, but I am happy to write to her with more detail, because the prevention and capability that is offered through screening is a great way of getting early treatment to people.